GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioCorRx Inc (OTCPK:BICX) » Definitions » Cyclically Adjusted Price-to-FCF

BICX (BioCorRx) Cyclically Adjusted Price-to-FCF : (As of May. 25, 2025)


View and export this data going back to 2009. Start your Free Trial

What is BioCorRx Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


BioCorRx Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for BioCorRx's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCorRx Cyclically Adjusted Price-to-FCF Chart

BioCorRx Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BioCorRx Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BioCorRx's Cyclically Adjusted Price-to-FCF

For the Medical Care Facilities subindustry, BioCorRx's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioCorRx's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BioCorRx's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where BioCorRx's Cyclically Adjusted Price-to-FCF falls into.


;
;

BioCorRx Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

BioCorRx's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, BioCorRx's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.046/134.9266*134.9266
=-0.046

Current CPI (Mar. 2025) = 134.9266.

BioCorRx Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -0.144 100.684 -0.193
201509 -0.070 100.392 -0.094
201512 0.339 99.792 0.458
201603 -0.201 100.470 -0.270
201606 -0.453 101.688 -0.601
201609 -0.439 101.861 -0.582
201612 -0.278 101.863 -0.368
201703 -0.413 102.862 -0.542
201706 -0.142 103.349 -0.185
201709 -0.232 104.136 -0.301
201712 -0.131 104.011 -0.170
201803 -0.166 105.290 -0.213
201806 -0.218 106.317 -0.277
201809 -0.172 106.507 -0.218
201812 -0.169 105.998 -0.215
201903 -0.137 107.251 -0.172
201906 -0.306 108.070 -0.382
201909 -0.267 108.329 -0.333
201912 -0.177 108.420 -0.220
202003 -0.127 108.902 -0.157
202006 -0.101 108.767 -0.125
202009 -0.111 109.815 -0.136
202012 -0.063 109.897 -0.077
202103 -0.155 111.754 -0.187
202106 -0.202 114.631 -0.238
202109 -0.099 115.734 -0.115
202112 -0.099 117.630 -0.114
202203 -0.130 121.301 -0.145
202206 -0.050 125.017 -0.054
202209 -0.051 125.227 -0.055
202212 -0.059 125.222 -0.064
202303 -0.051 127.348 -0.054
202306 -0.068 128.729 -0.071
202309 -0.041 129.860 -0.043
202312 -0.062 129.419 -0.065
202403 -0.039 131.776 -0.040
202406 -0.016 132.554 -0.016
202409 -0.033 133.029 -0.033
202412 -0.019 133.157 -0.019
202503 -0.046 134.927 -0.046

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BioCorRx  (OTCPK:BICX) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


BioCorRx Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of BioCorRx's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


BioCorRx Business Description

Traded in Other Exchanges
N/A
Address
2390 East Orangewood Avenue, Suite 500, Anaheim, CA, USA, 92806
BioCorRx Inc through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders. The BioCorRx Recovery Program is a non-addictive, medication assisted treatment program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application.
Executives
Louis C. Lucido director 2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Joseph J Galligan director, 10 percent owner 333 SOUTH GRAND AVENUE, 18TH FLOOR, LOS ANGELES CA 90071
Harsha Murthy director 5209 38TH STREET,NW, WASHINGTON DC 20015
Luisa Ingargiola director 4826 BLUE JAY CIRCLE, PALM HARBOR FL 34683
Thomas Patrick Welch officer: Vice President of Operations 10453 SARAH ST., TOLUCA LAKE CA 91602
Kent Emry director, officer: Chief Executive Officer 2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Brady James Granier director 13024 DELANO STREET, VALLEY GLEN CA 91401
Lourdes Felix director, officer: Chief Financial Officer 15 CALLE VERANO, RANCHO SANTA MARGARITA CA 92688
Jorge Jr Andrade director, officer: Chief Executive Officer PO BOX 5366, SANTA ANA CA 92704
Muller Neil Terrence Mr director, officer: President 13231 SANDHURST PLACE, SANTA ANA CA 92705